Insmed Incorporated (INSM) Price and Market Data

Insmed, Inc. is a biopharmaceutical company with a commercial portfolio and clinical pipeline focused on three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare diseases. Its two marketed products, Arikayce and Brinsupri, are both within the Respiratory segment. The company’s clinical-stage pipeline includes TPIP, INS1148, brensocatib, and INS1201, targeting multiple therapeutic areas. Insmed also advances preclinical research across a range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. The United States represents the company’s largest source of revenue, driven by sales of its commercial products.